
About Bioclinical Pharmaceuticals Private Limited
Data last updated:
Bioclinical Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 03 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2014PTC152412. Its GSTIN is 09AAGCB0334H1ZY (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arun Pratap Singh and Varun Singh.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 178/1 Kalate Nagar Near Pooja Masala Wakad, Pune, Maharashtra, India – 411027.
As per the financials filed for FY 2022, the company reported a revenue of ₹30.41 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net loss of ₹9,920 (net margin -0.3%) and EBITDA of -₹9,920 (EBITDA margin -0.3%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bioclinicalpharmaceuticals.co.in.
Company details
Contact details
Bioclinical Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its website is bioclinicalpharmaceuticals.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address178/1 Kalate Nagar Near Pooja Masala Wakad, Pune, Maharashtra, India – 411027
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Bioclinical Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bioclinical Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bioclinical Pharmaceuticals Private Limited, buy the company report.
Financials of Bioclinical Pharmaceuticals Private Limited
FY 2022 filings availableBioclinical Pharmaceuticals Private Limited reported revenue of ₹30.41 Lakh (up 47% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 47% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9,920 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9,920 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.3% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioclinical Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bioclinical Pharmaceuticals Private Limited
Bioclinical Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Pratap Singh | Director | 03 Sep 2014 | 12 Years 2 Months | Current |
| Varun Singh | Director | 03 Sep 2014 | 12 Years 2 Months | Current |
| Shivangi Singh | Director | 01 Feb 2025 | 1 Years 9 Months | Current |
Peer comparison
Bioclinical Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Accipere Pharmaceuticals Private Limited | ₹30.61 Lakh (FY 2025) | 0.0% | Kollam, Kerala, India | |||
| Macnis Pharmaceuticals Private Limited | ₹30.55 Lakh (FY 2023) | 27.0% | Delhi, India | |||
| Keryx Pharmaceuticals Private Limited | ₹30.46 Lakh (FY 2025) | 33.0% | Mohali, Punjab, India | |||
| Ackrose Pharmaceuticals Private Limited | ₹30.44 Lakh (FY 2025) | -35.0% | Delhi, India | |||
| Bioclinical Pharmaceuticals Private Limitedthis company | ₹30.41 Lakh (FY 2022) | -₹9,920 | -0.3% | 47.0% | Pune, Maharashtra, India | |
| Maxelon Pharmaceuticals Private Limited | ₹30.23 Lakh (FY 2025) | 5.0% | Naini, Uttar Pradesh, India | |||
| Thebes Pharmaceuticals Private Limited | ₹30.2 Lakh (FY 2025) | 58.0% | New Delhi, Delhi, India | |||
| Giniva Pharmaceuticals Private Limited | ₹30.19 Lakh (FY 2024) | -30.0% | Ellisbridge, Ahmedabad, Gujarat, India |
To see the full peer comparison of Bioclinical Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bioclinical Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioclinical Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bioclinical Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCB0334H1ZY | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bioclinical Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bioclinical Pharmaceuticals Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Shivangi Singh was appointed as Director on 01 Feb 2025.
Frequently asked questions
Bioclinical Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 03 September 2014 (12+ years old) and is registered under CIN U51909PN2014PTC152412.
Bioclinical Pharmaceuticals has 3 current directors:
- Arun Pratap Singh - Director
- Varun Singh - Director
- Shivangi Singh - Director
The latest financial statements of Bioclinical Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Bioclinical Pharmaceuticals is 09AAGCB0334H1ZY, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bioclinical Pharmaceuticals is U51909PN2014PTC152412. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioclinical Pharmaceuticals was incorporated on 03 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Bioclinical Pharmaceuticals by revenue are Accipere Pharmaceuticals Private Limited, Macnis Pharmaceuticals Private Limited, Keryx Pharmaceuticals Private Limited, Ackrose Pharmaceuticals Private Limited, Maxelon Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Shivangi Singh was appointed as Director on 01 Feb 2025. Yogesh Bajpai ceased to be Director on 15 Nov 2018. Arun Pratap Singh was appointed as Director on 03 Sep 2014. Bioclinical Pharmaceuticals has 4 board changes on record in total.
Bioclinical Pharmaceuticals can be reached through the website bioclinicalpharmaceuticals.co.in. Its registered office is in Pune, Maharashtra, India.
The registered office of Bioclinical Pharmaceuticals is at 1781 Kalate Nagar Near Pooja Masala Wakad, Pune, Maharashtra, India – 411027.
Bioclinical Pharmaceuticals operates in the trading industry, in the other wholesale segment.

